Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 962
Recruiting: 551
Ph III recruiting: 55
Growth YoY: +9.2%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (703)

clinicaltrialsPublishedShowing 551–600 of 1,136 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06497062	Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia	active not recruiting	Phase 2	47	Shanghai Jiao Tong University School of MedicineOTHER	1	Apr 30, 2026	clinicaltrials
NCT07420790	Design and Validation of a Generative AI and Propensity Score Matching Model for the VEN-DEC Phase II Study in Elderly AML Eligible for Allo-SCT; Evaluation of an Exploratory Approach Respect to a Randomized Phase III Trial(VenDec-AI)	recruiting	—	1,941	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia